Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus-Induced Hepatocellular Carcinoma Treated with PD-1 Inhibitors

PURPOSE: To investigate the prognostic value of blood markers in patients with hepatitis B virus (HBV)-induced hepatocellular carcinoma (HCC) treated with PD-1 inhibitors. Patients and Methods. We retrospectively collected and analyzed the clinicopathological data of 110 HBV-induced HCC patients tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Rui, Zheng, Yanfen, Zou, Wenxue, Liu, Chao, Liu, Jibing, Yue, Jinbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402369/
https://www.ncbi.nlm.nih.gov/pubmed/36033384
http://dx.doi.org/10.1155/2022/3781109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402369/
https://www.ncbi.nlm.nih.gov/pubmed/36033384
http://dx.doi.org/10.1155/2022/3781109

Ejemplares similares